Latest News about ABCM
Recent news which mentions ABCM
Danaher Bears The Brunt Of Macro Woes: Analyst Flags Lower Demand, Reduced Funding & Weakness In China
September 27, 2023
From Benzinga
The 3 Best Pharma Stocks to Buy Now: September 2023
September 08, 2023
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 30, 2023
August 30, 2023
From Benzinga
From Benzinga
Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings
August 29, 2023
From Benzinga
Goldman Sachs selling Personal Financial Management (PFM) unit in busy day for M&A deals
August 28, 2023
From MarketWatch
Health Care Company Danaher Announces Acquisition of Abcam
August 28, 2023
From Benzinga
From Benzinga
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
June 20, 2023
From Benzinga
From Benzinga
From Benzinga
Why Shares in Abcam Surged This Week
June 15, 2023
From Motley Fool
Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 14, 2023
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 30, 2023
From Benzinga
Dada Nexus, Bilibili And Other Big Stocks Moving Lower On Monday
January 30, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
From Benzinga
RH, HUYA, Bilibili And Some Other Big Stocks Moving Lower On Monday
December 12, 2022
From Benzinga
Hibbett, Enfusion And Some Other Big Stocks Moving Lower On Tuesday
November 29, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 29, 2022
From Benzinga
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
November 28, 2022
From Benzinga
Why DraftKings Shares Are Trading Lower By 5%; Here Are 24 Stocks Moving Premarket
November 28, 2022
From Benzinga
Univar Solutions, Anheuser-Busch InBev And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 28, 2022
From Benzinga
Cambridge biotech opts for Nasdaq listing over LSE’s AIM
September 13, 2022
Tickers
ABCM
From MarketWatch